trabectedin (Yondelis®) not recommended for use within NHSScotland

Source:
Scottish Medicines Consortium - SMC
Publisher:
Scottish Medicines Consortium
Publication date:
09 December 2019

Abstract

The SMC does not recommend trabectedin for the treatment of adults with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. Clinical and economic analyses submitted to the SMC were not sufficiently robust.